9-133473505-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_017585.4(SLC2A6):c.1132G>A(p.Glu378Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000812 in 1,601,400 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017585.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC2A6 | NM_017585.4 | c.1132G>A | p.Glu378Lys | missense_variant | 8/10 | ENST00000371899.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC2A6 | ENST00000371899.9 | c.1132G>A | p.Glu378Lys | missense_variant | 8/10 | 1 | NM_017585.4 | P1 | |
SLC2A6 | ENST00000371897.8 | c.1037-255G>A | intron_variant | 2 | |||||
SLC2A6 | ENST00000485978.1 | n.2099G>A | non_coding_transcript_exon_variant | 6/8 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152096Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000129 AC: 3AN: 231978Hom.: 0 AF XY: 0.0000238 AC XY: 3AN XY: 125812
GnomAD4 exome AF: 0.00000828 AC: 12AN: 1449304Hom.: 0 Cov.: 33 AF XY: 0.00000972 AC XY: 7AN XY: 720116
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152096Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74278
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 06, 2023 | The c.1132G>A (p.E378K) alteration is located in exon 8 (coding exon 8) of the SLC2A6 gene. This alteration results from a G to A substitution at nucleotide position 1132, causing the glutamic acid (E) at amino acid position 378 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at